Ceredex Value Advisors’s VeriSign VRSN Stock Holding History

Ceredex Value Advisors’s Portfolio VRSN Stock Details VRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80,400	Closed	-$20M	–	204
2026 Q1	$20M	Buy	+80,400	New	+$19.1M	0.63%	70

Other funds holding VRSN

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Ceredex Value Advisors's VRSN Position: Q2 2026 in Review

Ceredex Value Advisors sold out of VeriSign (VRSN) in Q2 2026, closing a stake of 80,400 shares — an estimated $20M sold.

Ceredex Value Advisors first reported a position in VRSN in Q1 2026 and held it in 1 quarter. The position peaked at $20M in Q1 2026. 879 funds tracked by Wall St. Rank hold VRSN as of Q2 2026.

Ceredex Value Advisors reported no remaining VeriSign position as of Q2 2026 after selling out during the quarter.
Ceredex Value Advisors sold 80,400 VeriSign shares in Q2 2026, an estimated $20M.
Ceredex Value Advisors first reported a position in VeriSign in Q1 2026 and held it in 1 quarter.
Ceredex Value Advisors's VeriSign position peaked at $20M in Q1 2026.
879 funds tracked by Wall St. Rank held VeriSign as of Q2 2026.

Based on Ceredex Value Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.